Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules
- Supplementary File 1:
ZIP-Document (ZIP, 225 KiB)
Datta-Mannan, A.; Brown, R.; Key, S.; Cain, P.; Feng, Y. Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules. Antibodies 2022, 11, 2. https://doi.org/10.3390/antib11010002
Datta-Mannan A, Brown R, Key S, Cain P, Feng Y. Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules. Antibodies. 2022; 11(1):2. https://doi.org/10.3390/antib11010002
Chicago/Turabian StyleDatta-Mannan, Amita, Robin Brown, Stephanie Key, Paul Cain, and Yiqing Feng. 2022. "Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules" Antibodies 11, no. 1: 2. https://doi.org/10.3390/antib11010002